Olaparib and pancreatic cancer: A challenging Lesson

被引：1
|
作者：
Louvet, Christophe [1 ]
Samalin, Emmanuelle [2 ]
Michel, Pierre [3 ]
机构：
[1] Inst Mutualiste Montsouris, Dept Med Oncol, F-75014 Paris, France
[2] Univ Montpellier, Inst Canc Montpellier Val Aurelle, Unite Oncol Gigest, Grp Digestif Unicanc, F-34298 Montpellier 5, France
[3] Normandie Univ, Hop Univ Rouen, Serv Hepatogastroenterol, UNIROUEN,Inserm 1245,IRON Grp,FFCD, F-76000 Rouen, France
来源：
BULLETIN DU CANCER | 2019年 / 106卷 / 09期
关键词：
D O I：
10.1016/j.bulcan.2019.07.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：715 / 716
页数：2
相关论文
共 50 条
  • [21] COMPARATIVE BENEFIT OF OLAPARIB IN RECURRENT BRCAM OVARIAN, BREAST, PANCREATIC AND PROSTATE CANCER
    Peters, P.
    Manrriquez, E.
    Amanam, I.
    Chan, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A47 - A47
  • [22] Efficacy and safety of olaparib as a potential treatment for patients with pancreatic cancer: a systematic review
    Chang, C. Charlie
    Putri, N. S.
    Joe, J.
    Pamula, M. J.
    Kua, K.
    Santoso, K. J. A.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1330 - S1330
  • [23] MET inhibitor enhances efficacies of gemcitabine and olaparib in pancreatic cancer cells.
    Chen, Meikuang
    Gao, Yuan
    Yu, Dihua
    Hung, Mien-Chie
    CANCER RESEARCH, 2021, 81 (13)
  • [24] Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective
    Feng, Xu
    Chai, Yi-Han
    Jiang, Ke-Xin
    Jiang, Wen-Bin
    Chen, Wen-Chao
    Pan, Yu
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (11)
  • [25] Opinion on the Benefit Assessment of Olaparib (new Indication, Pancreatic Cancer, Maintenance Therapy)
    Jansen, Petra Lynen
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (05): : 483 - 488
  • [26] Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy
    N Moniaux
    M Andrianifahanana
    R E Brand
    S K Batra
    British Journal of Cancer, 2004, 91 : 1633 - 1638
  • [27] Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging
    L. D. Dickerson
    A. Farooq
    F. Bano
    J. Kleeff
    R. Baron
    M. Raraty
    P. Ghaneh
    R. Sutton
    P. Whelan
    F. Campbell
    P. Healey
    J. P. Neoptolemos
    V. S. Yip
    World Journal of Surgery, 2019, 43 : 1604 - 1611
  • [28] Familial pancreatic cancer: challenging diagnostic approach and therapeutic management
    Mastoraki A.
    Chatzimavridou-Grigoriadou V.
    Chatzipetrou V.
    Mastoraki S.
    Papanikolaou I.S.
    Danias N.
    Smyrniotis V.
    Arkadopoulos N.
    Journal of Gastrointestinal Cancer, 2014, 45 (3) : 256 - 261
  • [29] Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy
    Moniaux, N
    Andrianifahanana, M
    Brand, RE
    Batra, SK
    BRITISH JOURNAL OF CANCER, 2004, 91 (09) : 1633 - 1638
  • [30] Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging
    Dickerson, L. D.
    Farooq, A.
    Bano, F.
    Kleeff, J.
    Baron, R.
    Raraty, M.
    Ghaneh, P.
    Sutton, R.
    Whelan, P.
    Campbell, F.
    Healey, P.
    Neoptolemos, J. P.
    Yip, V. S.
    WORLD JOURNAL OF SURGERY, 2019, 43 (06) : 1604 - 1611
12345